Zepp Health (NYSE:ZEPP) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of $0.30 by 96.67 percent. The company reported quarterly sales of $84.500 million which missed the analyst consensus estimate of $675.703 million by 87.49 percent. This is a 45.62 percent decrease over sales of $155.386 million the same period last year.
Zepp Health Q4 2023 Adj EPS $0.01 Misses $0.30 Estimate, Sales $84.500M Miss $675.703M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.